BioCryst Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/02/2025 | 22.77 M | $170.77 M | 3.05% | 10.90% |
| VANGUARD GROUP INC | 05/09/2025 | 21.66 M | $162.45 M | -1.05% | 10.37% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2025 | 8.93 M | $66.96 M | -1.73% | 4.27% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2025 | 8.70 M | $65.25 M | -26.68% | 4.17% |
| STATE STREET CORP | 05/15/2025 | 7.81 M | $58.60 M | 4.19% | 3.74% |
| ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 7.21 M | $54.11 M | 1.69% | 3.45% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2025 | 5.19 M | $38.92 M | -36.28% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 4.96 M | $37.21 M | 2.84% | 2.37% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 3.81 M | $28.60 M | 382.58% | 1.83% |
| TWO SIGMA ADVISERS, LP | 05/15/2025 | 3.22 M | $24.16 M | 28.84% | 1.54% |
| CALIGAN PARTNERS LP | 05/15/2025 | 3.11 M | $23.31 M | 3.73% | 1.49% |
| FISHER ASSET MANAGEMENT, LLC | 05/14/2025 | 3.05 M | $22.89 M | -4.10% | 1.46% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 2.88 M | $21.64 M | -1.93% | 1.38% |
| UBS GROUP AG | 05/13/2025 | 2.40 M | $18.02 M | 899.86% | 1.15% |
| EVERSEPT PARTNERS, LP | 05/15/2025 | 2.17 M | $16.29 M | 9.70% | 1.04% |
| MORGAN STANLEY | 05/15/2025 | 2.30 M | $17.23 M | 37.94% | 1.10% |
| JUPITER ASSET MANAGEMENT LTD | 05/09/2025 | 2.15 M | $16.12 M | 82.44% | 1.03% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 2.05 M | $15.34 M | 15.29% | 0.98% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 2.03 M | $15.25 M | 28.72% | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/01/2025 | 2.03 M | $15.21 M | -2.58% | 0.97% |
| NORTHERN TRUST CORP | 05/13/2025 | 1.96 M | $14.66 M | -2.48% | 0.94% |
| GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.93 M | $14.49 M | 49.62% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.92 M | $14.42 M | -2.93% | 0.92% |
| STIFEL FINANCIAL CORP | 05/14/2025 | 1.84 M | $13.78 M | -0.33% | 0.88% |
| AMERIPRISE FINANCIAL INC | 05/14/2025 | 1.75 M | $13.10 M | 1.55% | 0.84% |
| D. E. SHAW & CO., INC. | 05/15/2025 | 1.59 M | $11.92 M | 404.06% | 0.76% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 1.44 M | $10.77 M | 59.55% | 0.69% |
| 05/12/2025 | 1.42 M | $17.23 M | 100.00% | 0.68% | |
| SEGALL BRYANT & HAMILL, LLC | 05/02/2025 | 1.33 M | $9.98 M | -6.46% | 0.64% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 1.32 M | $9.93 M | -4.36% | 0.63% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.20 M | $9.01 M | 43.15% | 0.58% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.07 M | $7.99 M | 124.63% | 0.51% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 1.04 M | $7.82 M | 64.46% | 0.50% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2025 | 1.00 M | $7.50 M | 361.34% | 0.48% |
| LEGAL & GENERAL GROUP PLC | 05/15/2025 | 981.22 K | $7.36 M | 256.70% | 0.47% |
| INVESCO LTD. | 05/12/2025 | 968.16 K | $7.26 M | -9.74% | 0.46% |
| ALGERT GLOBAL LLC | 05/13/2025 | 960.06 K | $7.20 M | 32.37% | 0.46% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 940.67 K | $7.05 M | 244.76% | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 800.00 K | $6.00 M | 0.00% | 0.38% |
| PDT PARTNERS, LLC | 05/15/2025 | 778.73 K | $5.84 M | 49.10% | 0.37% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 764.90 K | $5.74 M | 112.54% | 0.37% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 670.36 K | $5.02 M | 244.13% | 0.32% |
| PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 612.32 K | $4.80 M | 2,215.73% | 0.29% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 612.22 K | $4.59 M | 181.17% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 605.22 K | $4.54 M | 11.04% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 589.88 K | $4.42 M | -1.18% | 0.28% |
| PRUDENTIAL FINANCIAL INC | 05/13/2025 | 589.31 K | $4.42 M | -40.05% | 0.28% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 586.21 K | $4.40 M | 10.68% | 0.28% |
| FMR LLC | 05/12/2025 | 583.61 K | $4.38 M | -24.91% | 0.28% |
| CITADEL ADVISORS LLC | 05/15/2025 | 574.19 K | $4.31 M | 122.08% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioCryst Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 309 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Merit Financial Group, LLC: 0
MATHER GROUP, LLC.: 0
Diversified Trust Co: 0
BlackRock, Inc.: 22.77 M
VANGUARD GROUP INC: 21.66 M
Kynam Capital Management, LP: 8.93 M
81.47% of BioCryst Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 207.47 M shares in the last 24 months. This purchase volume represents approximately $1.79 B in transactions.